Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

Miao X, Yang ZL, Xiong L, Zou Q, Yuan Y, Li J, Liang L, Chen M, Chen S.

Int J Clin Exp Pathol. 2013;6(2):179-90. Epub 2013 Jan 15.

2.

Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

Yuan Y, Yang ZL, Zou Q, Li JH, Li DQ, Liang LF, Zeng GX, Chen SL.

Neoplasma. 2013;60(6):698-705. doi: 10.4149/neo_2013_089.

PMID:
23906305
3.

ACE2 and FZD1 are prognosis markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of gallbladder.

Li J, Yang ZL, Ren X, Zou Q, Yuan Y, Liang L, Chen M, Chen S.

J Mol Histol. 2014 Feb;45(1):47-57. doi: 10.1007/s10735-013-9528-1. Epub 2013 Aug 7.

PMID:
23921915
4.

N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.

Yi S, Yang ZL, Miao X, Zou Q, Li J, Liang L, Zeng G, Chen S.

Pathol Res Pract. 2014 Jun;210(6):363-8. doi: 10.1016/j.prp.2014.01.014. Epub 2014 Feb 22.

PMID:
24636838
5.

MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.

Liu Z, Yang Z, Jiang S, Zou Q, Yuan Y, Li J, Li D, Liang L, Chen M, Chen S.

Mol Med Rep. 2016 Nov;14(5):4581-4592. doi: 10.3892/mmr.2016.5851. Epub 2016 Oct 13.

6.

Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.

Zou Q, Yang ZL, Yuan Y, Li JH, Liang LF, Zeng GX, Chen SL.

World J Surg Oncol. 2013 Jun 19;11:143. doi: 10.1186/1477-7819-11-143.

7.

ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

Li J, Yang ZL, Ren X, Zou Q, Yuan Y, Liang L, Chen M, Chen S.

Tumour Biol. 2013 Feb;34(1):359-68. doi: 10.1007/s13277-012-0557-2. Epub 2012 Oct 13.

PMID:
23065574
8.

The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance.

Liu L, Yang ZL, Wang C, Miao X, Liu Z, Li D, Zou Q, Li J, Liang L, Zeng G, Chen S.

Pathol Oncol Res. 2016 Jul;22(3):483-92. doi: 10.1007/s12253-015-0019-4. Epub 2015 Dec 3.

PMID:
26634853
9.

A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder.

Yang Z, Yang Z, Zou Q, Yuan Y, Li J, Li D, Liang L, Zeng G, Chen S.

Int J Clin Oncol. 2014 Apr;19(2):325-35. doi: 10.1007/s10147-013-0550-9. Epub 2013 Apr 17.

PMID:
23592278
10.

Paxillin and carbonic anhydrase IX are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.

Liu Z, Yang Z, Jiang S, Zou Q, Yuan Y, Li J, Li D, Liang L, Chen M, Chen S.

Histopathology. 2014 Jun;64(7):921-34. doi: 10.1111/his.12341. Epub 2014 Feb 5.

PMID:
24354963
11.

The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas.

Liang S, Yang Z, Li D, Miao X, Yang L, Zou Q, Yuan Y.

Dis Markers. 2015;2015:379568. doi: 10.1155/2015/379568. Epub 2015 Jul 30.

12.

ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer.

Sun J, Yang ZL, Miao X, Zou Q, Li J, Liang L, Zeng G, Chen S.

J Mol Histol. 2015 Feb;46(1):57-65. doi: 10.1007/s10735-014-9597-9. Epub 2014 Oct 14.

PMID:
25311765
13.

Squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder: an immunohistochemistry study of prognostic markers.

Li J, Yang ZL, Zou Q, Yuan Y, Li J, Liang L, Zhen G, Chen S.

Pathol Oncol Res. 2014 Apr;20(2):285-92. doi: 10.1007/s12253-013-9693-2. Epub 2013 Sep 28.

PMID:
24078426
14.

EphB1 and Ephrin-B, new potential biomarkers for squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder.

Yuan Y, Yang ZL, Miao XY, Liu ZR, Li DQ, Zou Q, Li JH, Liang LF, Zeng GX, Chen SL.

Asian Pac J Cancer Prev. 2014;15(3):1441-6.

15.

TSG101 and PEG10 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder.

Liu Z, Yang Z, Liu D, Li D, Zou Q, Yuan Y, Li J, Liang L, Chen M, Chen S.

Oncol Lett. 2014 Apr;7(4):1128-1138. Epub 2014 Feb 14.

16.

CFL1 and Arp3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinomas of gallbladder.

Yang ZL, Miao X, Xiong L, Zou Q, Yuan Y, Li J, Liang L, Chen M, Chen S.

Cancer Invest. 2013 Feb;31(2):132-9. doi: 10.3109/07357907.2012.756113. Epub 2013 Jan 15.

PMID:
23320827
17.

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

Li J, Yang Z, Zou Q, Yuan Y, Li J, Liang L, Zeng G, Chen S.

Clin Transl Oncol. 2014 Feb;16(2):200-7. doi: 10.1007/s12094-013-1063-8. Epub 2013 Jun 21. Erratum in: Clin Transl Oncol. 2014 Feb;16(2):224.

PMID:
23793810
18.

DNA-PKcs and Ku70 are predictive markers for poor prognosis of patients with gall bladder malignancies.

Ren F, Yang ZL, Tan X, Liu D, Zou Q, Yuan Y, Li J, Liang L, Zeng G, Chen S.

Appl Immunohistochem Mol Morphol. 2014 Nov-Dec;22(10):741-7. doi: 10.1097/PAI.0000000000000017.

PMID:
25046228
19.

Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder.

Wu ZC, Xiong L, Wang LX, Miao XY, Liu ZR, Li DQ, Zou Q, Liu KJ, Zhao H, Yang ZL.

World J Gastroenterol. 2017 Apr 14;23(14):2601-2612. doi: 10.3748/wjg.v23.i14.2601.

20.

The clinicopathological significance of Jagged1 and DLL4 in gallbladder cancer.

Luo Y, Yang ZL, Wang C, Miao X, Liu Z, Li D, Zou Q, Li J, Liang L, Zeng G, Chen S.

Tumori. 2016 May 6:0. doi: 10.5301/tj.5000519. [Epub ahead of print]

PMID:
27174628

Supplemental Content

Support Center